Novel Therapeutic Strategies Targeting Molecular Pathways of Cystogenesis in Autosomal Polycystic Kidney Disease
Autosomal dominant polycystic kidney disease (ADPKD) is the most common inherited kidney disease that results from mutations in PKD1 or PKD2. The disease is characterized by the progressive development of fluid-filled cysts derived from renal tubular epithelial cells that destroy the architecture of...
Main Authors: | Maurizio Salvadori, Aris Tsalouchos |
---|---|
Format: | Article |
Language: | English |
Published: |
Codon Publications
2017-03-01
|
Series: | Journal of Renal and Hepatic Disorders |
Subjects: | |
Online Access: | https://jrenhep.com/index.php/jrenhep/article/view/10 |
Similar Items
-
New Therapies Targeting Cystogenesis in Autosomal Polycystic Kidney Disease
by: Maurizio Salvadori, et al.
Published: (2017-07-01) -
Autosomal Dominant Polycystic Kidney Disease: From Pathophysiology of Cystogenesis to Advances in the Treatment
by: Jana Reiterová, et al.
Published: (2022-03-01) -
Autosomal Dominant Polycystic Kidney Disease: What Do We Need To Know For Counselling?
by: Giorgina Barbara Piccoli, et al.
Published: (2014-07-01) -
Differential Expression of -Associated Genes in Autosomal Dominant Polycystic Kidney Disease
by: Yeon Joo Yook, et al.
Published: (2012-03-01) -
Pathways, perspectives and pursuits in polycystic kidney disease
by: Bhaskar L. V. K. S., et al.
Published: (2016-01-01)